drugset / Trial / NCT06112678

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

NCT06112678

Phase 1 Completed 63 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348(6).

Timeline

Start
2024-01-04
Primary completion
2024-02-19
Completion
2024-03-18

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-348(6) Unknown Oral
Subject CKD-828 Unknown Oral
Subject D097 Unknown Oral
Subject D337 Unknown Oral